TSX News -
Westport Fuel Systems to Announce First Quarter Results on Thursday, June 4, 2020
VANCOUVER, British Columbia, April 29, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems” or the “Company”) (TSX:WPRT […]
TSX News -
CCL to Hold Conference Call to Discuss First Quarter Results, Thursday May 14, 2020, at 7:30 a.m. EDT
TORONTO, April 29, 2020 (GLOBE NEWSWIRE) — CCL Industries Inc. (TSX:CCL.A) (TSX:CCL.B), a world leader in specialty label, security and […]
Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program
TORONTO, April 29, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences […]
KEMET Provides Regulatory Update for Pending Acquisition by Yageo Corporation
FORT LAUDERDALE, Fla., April 29, 2020 (GLOBE NEWSWIRE) — KEMET Corporation (“KEMET”) (NYSE: KEM) today announced that, in connection with […]
Sun Communities, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
Southfield, Michigan, April 29, 2020 (GLOBE NEWSWIRE) — Sun Communities, Inc. (NYSE:SUI) (the “Company”), a real estate investment trust (“REIT”) that […]
Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable […]
RigNet Announces First Quarter 2020 Earnings Release Date and Earnings Call Information
HOUSTON, April 29, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its first quarter […]
Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models
REDWOOD CITY, Calif., April 29, 2020 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on […]
AzurRx BioPharma Receives Approval to Conduct its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis Therapeutics Development Network Sites
On track to initiate the OPTION 2 trial by the end of Q2 2020OPTION 2 trial to compare efficacy of […]
Fidelity D & D Bancorp, Inc. Reports First Quarter 2020 Financial Results
DUNMORE, Pa., April 29, 2020 (GLOBE NEWSWIRE) — Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC) and its banking subsidiary […]
